EICHOR
● Terminated
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Condition: Non Infectious Uveitis · Sponsor: Santen Inc.
About this study
This is a Phase III study to assess the efficacy and safety of DE-109 440 µg every 2 months in subjects with active, non-infectious uveitis of the posterior segment of the eye (NIU-PS). There is a 6-month, single-arm, open-label period after completion of the 6-month double- masked, controlled period allows the evaluation of the efficacy and safety of intravitreal injection of DE-109 440 µg every 2 months for longer duration than appropriate for a placebo or sham control.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (65)
| Arizona Retina & Vitreous Consultants | Phoenix, Arizona, United States | — |
| Retina-Vitreous Associates Medical Group | Beverly Hills, California, United States | — |
| Kaiser Permanente Medical Center | Los Angeles, California, United States | — |
| USC Roski Eye Institute | Los Angeles, California, United States | — |
| Byers Eye Institute at Stanford | Palo Alto, California, United States | — |
| California Eye Specialist Medical Group, Inc. | Pasadena, California, United States | — |
| Colorado Retina Associates | Golden, Colorado, United States | — |
| Retina Vitreous Associates of Florida | St. Petersburg, Florida, United States | — |
| University of South Florida Eye Institute | Tampa, Florida, United States | — |
| Emory Eye Center | Atlanta, Georgia, United States | — |
| Marietta Eye Clinic | Marietta, Georgia, United States | — |
| Cook County Health & Hospitals System | Chicago, Illinois, United States | — |
+ 53 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.